Quick Answer
Park Ha Biological Technology Co., Ltd. reported Diluted EPS of $41.38 per share (loss) for fiscal year 2025.
Park Ha Biological Technology Co., Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$41.38 | -4410.4% |
| 2024 | $0.96 | -43.5% |
| 2023 | $1.70 | +16900.0% |
| 2022 | $0.01 | — |
- Park Ha Biological Technology Co., Ltd. showed a decrease of -4410.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Park Ha Biological Technology Co., Ltd.’s diluted eps has declined by 413900.0% (from $0.01 per share to $41.38 per share (loss)).
- The most recent figure is from Park Ha Biological Technology Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: